InvestSMART

Company announcements

leave blank for all companies
leave blank for all announcements
announcements

~ We have limited the announcement data displayed on our website to the past 12 months to ensure its accuracy and usefulness.
Search Results
Company Sector Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,593 Fast Track granted by FDA for NNZ-2591 in Pitt Hopkins 19 Feb 2025 1:00PM $13.300 $12.580 fallen by 5.41%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,593 Priority Review Voucher sale proceeds received 7 Feb 2025 12:03PM $13.980 $12.580 fallen by 10.01%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,593 Type C Meeting granted by FDA for Phelan-McDermid syndrome 7 Feb 2025 8:14AM $13.930 $12.580 fallen by 9.69%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,593 Neuren to present at autism research meeting 6 Feb 2025 9:09AM $13.760 $12.580 fallen by 8.58%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,593 NEU Presentations at ACMG Annual Clinical Genetics Meeting 22 Jan 2025 8:22AM $13.600 $12.580 fallen by 7.50%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,593 J.P. Morgan Healthcare Conference recap 20 Jan 2025 10:14AM $13.270 $12.580 fallen by 5.20%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,593 Neuren JP Morgan Healthcare Conference 2025 presentation 16 Jan 2025 10:26AM $11.620 $12.580 risen by 8.26%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,593 Trofinetide marketing application submitted in Europe 15 Jan 2025 9:26AM $12.000 $12.580 risen by 4.83%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,593 Update - Notification of buy-back - NEU 18 Dec 2024 8:51AM $13.160 $12.580 fallen by 4.41%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,593 Update - Notification of buy-back - NEU 17 Dec 2024 8:53AM $13.300 $12.580 fallen by 5.41%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,593 Update - Notification of buy-back - NEU 16 Dec 2024 9:13AM $13.320 $12.580 fallen by 5.56%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,593 Update - Notification of buy-back - NEU 13 Dec 2024 8:55AM $13.240 $12.580 fallen by 4.98%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,593 Priority Review Voucher sale complete 12 Dec 2024 9:31AM $13.440 $12.580 fallen by 6.40%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,593 Update - Notification of buy-back - NEU 12 Dec 2024 9:04AM $13.440 $12.580 fallen by 6.40%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,593 Update - Notification of buy-back - NEU 11 Dec 2024 9:35AM $12.970 $12.580 fallen by 3.01%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,593 Update - Notification of buy-back - NEU 10 Dec 2024 9:12AM $12.740 $12.580 fallen by 1.26%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,593 Update - Notification of buy-back - NEU 9 Dec 2024 8:36AM $12.800 $12.580 fallen by 1.72%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,593 Update - Notification of buy-back - NEU 6 Dec 2024 8:46AM $12.760 $12.580 fallen by 1.41%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,593 Update - Notification of buy-back - NEU 5 Dec 2024 8:19AM $12.880 $12.580 fallen by 2.33%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,593 Update - Notification of buy-back - NEU 4 Dec 2024 8:29AM $13.390 $12.580 fallen by 6.05%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,593 Update - Notification of buy-back - NEU 3 Dec 2024 9:14AM $12.690 $12.580 fallen by 0.87%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,593 Investor presentation, 15 November 2024 15 Nov 2024 10:19AM $16.990 $12.580 fallen by 25.96%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,593 Notification of buy-back - NEU 14 Nov 2024 9:17AM $16.540 $12.580 fallen by 23.94%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,593 Neuren announces A$50m on-market share buy-back program 14 Nov 2024 9:14AM $16.540 $12.580 fallen by 23.94%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,593 Q3 2024 update 7 Nov 2024 10:19AM $13.270 $12.580 fallen by 5.20%

151 - 175 of 799 results

Page 7 of 32

  • + Company announcements and prices are delayed by at least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.